NEWSLETTER February 2013 Brazil: Moscamed gear up for the next phase In December the Brazilian regulatory authority Comissao Tecnica Nacional de Biosseguranca (CTNBio) formally approved the next phase of using Oxitec’s Aedes aegypti product strain, OX513A, to help combat the wild mosquitoes that spread dengue. In this next phase Moscamed will treat the town of [...]
NEWSLETTER November 2012 Brazil update: Community support Following success in two settlements in the Brazilian state of Juazeiro, control of the dengue mosquito Aedes aegypti, by Oxitec in partnership with Brazil’s Moscamed, is expanding to new areas. Step-by-step trials in a neighbourhood of Itaberaba have resulted in effective reduction of the dengue mosquito population. Oxitec’s [...]
NEWSLETTER July 2012 Moscamed prepares for next phase in the development of Oxitec’s transgenic mosquitoes in Brazil Following successful open release trials in Brazil, Moscamed is now gearing up for the next phase of development in combatting the mosquitoes that spread dengue fever, with the launch of their new mosquito production facility. On Saturday 7 [...]
NEWSLETTER May 2012 Continuing the fight against the dengue mosquito in Brazil Critical to Oxitec’s approach to pest control is the ability to consistently rear large volumes of high quality insects, and this has been the case with our work in Brazil against the dengue vector mosquito, Aedes aegypti. In a partnership between Oxitec, Moscamed [...]
NEWSLETTER FEBRUARY 2012 Oxitec appoints Dr Christopher Richards as Chairman We are delighted to announce that Dr Chris Richards has joined us as Chairman with effect from January this year. In 20 years with ICI, Zeneca and Syngenta, he has gained wide experience in technical and commercial areas, including in ICI Public Health and general [...]
Oxitec announced this month that it is collaborating with Gangabishan Bhikulal Investment and Trading Limited (GBIT) to bring Oxitec’s RIDL® technology to India to help combat Aedes aegypti, the mosquito vector for the viral diseases dengue and chikungunya.
Field trials in Brazil: a progress report Click here for our latest newsletter Field work by our partner Moscamed with Oxitec’s lead RIDL® strain of the dengue mosquito Aedes aegypti is progressing rapidly near the city of Juazeiro, Brazil. Following a series of preliminary studies earlier in 2011 that showed highly promising results for optimised [...]
NEWSLETTER: JUNE 2011 UK Government backs moth genome research Oxitec and the Centre for Genomic Research (CGR) in Liverpool have won a competition for projects aiming to use genome sequencing to develop new products. The proposal ‘Gene discovery in the diamondback moth for novel pest control’ was selected for funding by the UK Government-backed Technology [...]
Cayman demonstrates RIDL® potential In November, the Cayman Islands Mosquito Research and Control Unit (MRCU) together with Oxitec announced the results of a trial carried out on Grand Cayman last summer. Around 3 million male sterile mosquitoes were released over several months. These releases reduced the local population of the dengue mosquito Aedes aegypti by [...]
NEWSLETTER OCTOBER 2010 New solution for tomato leaf miner Oxitec and a leading crop protection company have recently been awarded funding from the UK government funded Technology Strategy Board to develop RIDL® technology in the tomato leaf miner, Tuta absoluta. The companies will collaborate to create a RIDL strain of Tuta. If successful, the product [...]